Evis Sala: Returning Home to Transform Healthcare
Major Win for Childhood Cancer Advocacy: UN Adopts GICC Target
Marty Makary: FDA Rejection Letters are Now Public
FDA Approves RYBREVANT FASPRO as the First Subcutaneous Amivantamab Option for EGFR-Mutated NSCLC
David Steensma: Ajax Therapeutics Receives Orphan Drug Designation by FDA for AJ1-11095 for the Treatment of Myelofibrosis
FDA Awarded a National Priority Voucher to Teclistamab with Daratumumab for R/R Multiple Myeloma
Tom Powles: Another Step Towards Curing Bladder Cancer
Maryam Lustberg: From Phase 2 Promise to Phase 3 Proof in Neuropathy Prevention
The ESMO Virtual Journal Club: December 2025 is a one-hour virtual educational event exclusively for ESMO Members, scheduled for Wednesday, December 10, 2025, at 18:30 CET. Chaired by Dr. Anna […]
"Assessing Physical Function in Transplantation and CAR T Recipients" is a free panel-based webinar offered by the ASTCT Survivorship SIG (American Society for Transplantation and Cellular Therapy) and is scheduled […]
The FRPT (Flash Radiotherapy and Particle Therapy) 2025 Conference is a major multidisciplinary forum dedicated to uniting cutting-edge radiation therapies with groundbreaking research and clinical trials. The conference is scheduled for December 10–12, 2025, and will be held in Prague, the Czech Republic. Over three days, the event will showcase the latest updates on FLASH […]
The AOFOG-ASGO Gynecologic Oncology Research Workshop (AGORE) is scheduled for December 10–13, 2025, and will be held at the Skycity Marriott in Hong Kong. This event is specifically designed for gynecological oncology fellows and oncologists, offering a unique opportunity to enhance their research skills through a program featuring engaging lectures, mentoring sessions, and hands-on workshops, […]
The ESMO Immuno-Oncology Congress 2025 will be held from 10 to 12 December 2025 as a hybrid event, both onsite in London, UK, and online. This leading international congress brings together experts from around the globe to explore the full spectrum of immuno-oncology from basic science and translational research to clinical advancements. Attendees can expect […]
The ESMO-IO SITC Primer Program is a joint educational event organized by the European Society for Medical Oncology (ESMO) and the Society for Immunotherapy of Cancer (SITC), scheduled for December 10, 2025, from 8:30 a.m. to 12:00 p.m. BST. This half-day primer, held at the Queen Elizabeth II Centre in London, UK, focuses on fundamental […]
The educational webinar titled "The Role of Modern Radiotherapy for Low Grade Glioma," part of the Educational Lectures on Paediatric Radiation Oncology Series, will be held virtually on December 11, […]
The webinar "Advancing Pediatric ALL Care: Adapting Global Standards for LMICs" will be held virtually on Thursday, December 11, 2025, at 2 PM CET/Geneva. This session focuses on sharing Global Updates […]
"BMT Across the World: Who Makes What and Who Pays Whom?" is Part 1 of a joint educational series hosted by the ASTCT (American Society for Transplantation and Cellular Therapy) […]
The 33rd International TTD Symposium: Advances in the Treatment of Digestive Tumors is a two-day scientific meeting organized by the TTD Group (Digestive Tumor Treatment Group). The event will be held from December 11 to December 12, 2025, at the Exhibition and Congress Palace in Oviedo, Spain. The symposium will feature presentations and discussions on […]
The Best of ESMO India 2025 is an ESMO-licensed event making its Indian debut in Mumbai, scheduled for December 13–14, 2025. This conference, hosted by the Global Healthcare Academy (GHA), is a major platform for disseminating the most recent, cutting-edge data and clinical practices from the main European Society for Medical Oncology (ESMO) Congress. Designed for a multidisciplinary […]
The ESMO Preceptorship on Prostate Cancer 2025: Lugano is a two-day educational course focusing on a thorough understanding of prostate cancer management, from diagnosis to treatment, according to current standards […]